ARCHIVES

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

The Lancet Corrects Henschke Letters.

July 18, 2008

Diet Intervention Results Could Be Found In Months

April 4, 1986

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

NCI Reports On Efforts To Prevent Cancer In Native Americans

August 13, 1999